Related Experiment Video
Updated: Jan 7, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Understanding Left Ventricular Dysfunction in Liver Cirrhosis: Key Insights for Primary Care.
1Dr Smritimayee Panda, Academic Senior Resident, Department of Endocrinology, SGPGI, Lucknow, India.
Cardiac dysfunction, specifically diastolic dysfunction, is common in liver cirrhosis. Its prevalence increases with liver cirrhosis severity, as indicated by Child-Pugh and MELD-Na scores, but not the cause.
Area of Science:
- Cardiology
- Hepatology
- Medical Imaging
Background:
- Cardiac dysfunction is a frequent complication of liver cirrhosis.
- The link between cardiac dysfunction and liver cirrhosis severity requires further investigation.
- Understanding this relationship is crucial for managing liver cirrhosis patients.
Purpose of the Study:
- To investigate the association between liver cirrhosis severity and left ventricular diastolic dysfunction.
- To determine if liver cirrhosis severity scores correlate with the presence and grade of diastolic dysfunction.
Main Methods:
- A cross-sectional study involving 135 liver cirrhosis patients.
- Assessment of liver cirrhosis severity using Child-Pugh Score and MELD-Na Score.
- Evaluation of left ventricular diastolic function via 2D echocardiography.
Main Results:
- Diastolic dysfunction was present in 55.6% of patients.
- Higher MELD-Na scores (>19) and Child-Pugh Class C were associated with increased diastolic dysfunction prevalence.
- The severity of diastolic dysfunction did not correlate with the cause of cirrhosis (alcoholic vs. non-alcoholic).
Conclusions:
- Left ventricular diastolic dysfunction is prevalent in liver cirrhosis and its incidence rises with disease severity.
- Child-Pugh and MELD-Na scores are useful indicators of diastolic dysfunction risk in cirrhosis.
- The cause of cirrhosis does not influence the severity of diastolic dysfunction.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Heart Failure III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

